Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Axitinib × Clear all

NCT01385059 2023-03-07

Axitinib Before Surgery in Treating Patients With High-Risk Prostate Cancer

Phase 2 Completed

11 enrolled 10 charts

Prostatic Neoplasms